Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 10.26% is in line with its 2-year average of 10.93%, around the middle of its 2-year range (7.72%–12.87%).
3.07% above its 12-month average of 9.95%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 8.47%.
EBITDA MARGIN
10.26%
EBITDA MARGIN AVG TTM
9.95%
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+3.07%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$27.86B
EBITDA Margin
30.90%
TTM Avg
31.59%
3Y Avg
31.63%
5Y Avg
30.80%
Market Cap
$27.27B
EBITDA Margin
19.69%
TTM Avg
19.16%
3Y Avg
18.89%
5Y Avg
21.02%
Market Cap
$28.68B
EBITDA Margin
16.19%
TTM Avg
16.24%
3Y Avg
16.31%
5Y Avg
17.37%
Market Cap
$26.61B
EBITDA Margin
15.75%
TTM Avg
14.53%
3Y Avg
14.10%
5Y Avg
17.90%
Market Cap
$25.48B
EBITDA Margin
24.13%
TTM Avg
25.03%
3Y Avg
27.36%
5Y Avg
27.53%
Market Cap
$25.29B
EBITDA Margin
27.93%
TTM Avg
16.21%
3Y Avg
17.95%
5Y Avg
14.24%
Market Cap
$31.31B
EBITDA Margin
34.73%
TTM Avg
34.58%
3Y Avg
34.05%
5Y Avg
33.84%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medline Inc. (MDLN) | $27.90B | 10.26% | 9.95% | N/A | N/A |
| Mettler-Toledo International Inc. (MTD)vs › | $27.86B | 30.90% | 31.59% | 31.63% | 30.80% |
| Quest Diagnostics Incorporated (DGX)vs › | $27.27B | 19.69% | 19.16% | 18.89% | 21.02% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $28.68B | 16.19% | 16.24% | 16.31% | 17.37% |
| Labcorp Holdings Inc. (LH)vs › | $26.61B | 15.75% | 14.53% | 14.10% | 17.90% |
| West Pharmaceutical Services, Inc. (WST)vs › | $25.48B | 24.13% | 25.03% | 27.36% | 27.53% |
| Incyte Corporation (INCY)vs › | $25.29B | 27.93% | 16.21% | 17.95% | 14.24% |
| Zoetis Inc. (ZTS)vs › | $30.61B | 43.14% | 42.58% | 42.20% | 41.87% |
| Waters Corporation (WAT)vs › | $31.31B | 34.73% | 34.58% | 34.05% | 33.84% |
| BioNTech SE (BNTX)vs › | $24.07B | -9.29% | -23.11% | 12.60% | 20.38% |
Gross Margin
25.0%
EBITDA Margin
10.3%
Operating Margin
6.1%
Net Margin
2.3%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 8.47% |
| 2026-03-31 | 9.19% |
| 2025-12-31 | 7.72% |
| 2025-09-30 | 11.62% |
| 2025-06-30 | 12.77% |
| 2025-03-31 | 12.61% |
| 2024-09-30 | 12.87% |
| 2024-06-30 | 12.21% |
